One-Year Brolucizumab Outcomes in Neovascular Age-Related Macular Degeneration from a Large United States Cohort in the IRIS® Registry
Mathew W. MacCumber, Charles C. Wykoff, Hélène Karcher, Eser Adiguzel, Samriddhi Buxy Sinha, Saloni Vishwakarma, Andrew LaPrise, Franklin Igwe, Rita Freitas, Michael S. Ip, Marco A. Zarbin
Topics & Concepts
MedicineMacular degenerationOphthalmologyRetrospective cohort studyVisual acuityCohortDiabetic retinopathyChoroidal neovascularizationConfidence intervalAdverse effectCohort studySurgeryInternal medicineDiabetes mellitusEndocrinologyRetinal Diseases and TreatmentsOphthalmology and Visual Impairment StudiesRetinopathy of Prematurity Studies